CG

Chetan Gopaldas Cholera

Description

Chetan Gopaldas Cholera provides late-stage investments.

Investor Profile

Chetan Gopaldas Cholera has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series E (100%)

Country Focus

  • India (100%)

Industry Focus

  • E-commerce
  • Health Care
  • Health Diagnostics
  • Pharmaceutical
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Chetan Gopaldas Cholera frequently co-invest with?

LGT group
Europe, Vaduz, Liechtenstein, Vaduz
Co-Investments: 1
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Prosus Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Eight Roads Ventures India
Asia, Karnataka, India, Bangalore
Co-Investments: 1
Caisse de Depot et Placement du Quebec
North America, Quebec, Canada, Montréal
Co-Investments: 1
Think Investments
North America, California, United States, San Francisco
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
TPG Growth
North America, California, United States, San Francisco
Co-Investments: 1
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 1

Which angels does Chetan Gopaldas Cholera often collaborate with?

Shared Deals: 1
Shared Deals: 1
Dharmil Sheth
Asia, Maharashtra, India, Mumbai
Shared Deals: 1
Aditya Puri
Asia, Maharashtra, India, Mumbai
Shared Deals: 1
Shared Deals: 1
Dhaval Shah
Asia, Maharashtra, India, Mumbai
Shared Deals: 1
Shalibhadra Shah
Asia, Maharashtra, India, Mumbai
Shared Deals: 1
Siddharth Bhaskar Shah
Asia, Maharashtra, India, Mumbai
Shared Deals: 1

What are some of recent deals done by Chetan Gopaldas Cholera?

PharmEasy

Mumbai, Maharashtra, India

PharmEasy is an online health service that connects users to local pharmacies and labs for medicine delivery and diagnostic services.

E-CommerceHealth CareHealth DiagnosticsPharmaceuticalWellness
Series EApr 7, 2021
Amount Raised: $390,000,000